Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.

MLA

Motoki, Atsuko, et al. “Soluble Epoxide Hydrolase Inhibition and Gene Deletion Are Protective against Myocardial Ischemia-Reperfusion Injury in Vivo.” American Journal of Physiology. Heart and Circulatory Physiology, vol. 295, no. 5, Nov. 2008, pp. H2128–34. EBSCOhost, https://doi.org/10.1152/ajpheart.00428.2008.

APA

Motoki, A., Merkel, M. J., Packwood, W. H., Cao, Z., Liu, L., Iliff, J., Alkayed, N. J., & Van Winkle, D. M. (2008). Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. American Journal of Physiology. Heart and Circulatory Physiology, 295(5), H2128–H2134. https://doi.org/10.1152/ajpheart.00428.2008

Chicago

Motoki, Atsuko, Matthias J Merkel, William H Packwood, Zhiping Cao, Lijuan Liu, Jeffrey Iliff, Nabil J Alkayed, and Donna M Van Winkle. 2008. “Soluble Epoxide Hydrolase Inhibition and Gene Deletion Are Protective against Myocardial Ischemia-Reperfusion Injury in Vivo.” American Journal of Physiology. Heart and Circulatory Physiology 295 (5): H2128–34. doi:10.1152/ajpheart.00428.2008.